|
US5082767A
(en)
|
1989-02-27 |
1992-01-21 |
Hatfield G Wesley |
Codon pair utilization
|
|
US6140496A
(en)
|
1990-10-09 |
2000-10-31 |
Benner; Steven Albert |
Precursors for deoxyribonucleotides containing non-standard nucleosides
|
|
US5891680A
(en)
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US5811097A
(en)
|
1995-07-25 |
1998-09-22 |
The Regents Of The University Of California |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
|
US5922685A
(en)
|
1996-06-05 |
1999-07-13 |
Powderject Vaccines, Inc. |
IL-12 gene therapy of tumors
|
|
WO1998017814A2
(en)
|
1996-10-18 |
1998-04-30 |
Valentis Inc. |
Gene expression and delivery systems and uses
|
|
US5994104A
(en)
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
|
WO1999024595A1
(en)
|
1997-11-12 |
1999-05-20 |
The Brigham And Women's Hospital, Inc. |
The translation enhancer element of the human amyloid precursor protein gene
|
|
DE69815707T2
(de)
|
1997-11-20 |
2004-07-01 |
Vical, Inc., San Diego |
Behandlung von krebs durch verwendung von zytokin-exprimierender polynukleotiden und zusammensetzungen dafür
|
|
CA2326725A1
(en)
|
1998-04-23 |
1999-10-28 |
Takara Shuzo Co., Ltd. |
Method for synthesizing dna
|
|
AU761520B2
(en)
|
1998-09-15 |
2003-06-05 |
Genetics Institute, Llc |
Treatment of Kaposi's Sarcoma with IL-12
|
|
WO2000018778A1
(en)
|
1998-09-29 |
2000-04-06 |
Phylos, Inc. |
Synthesis of codon randomized nucleic acids
|
|
IL148079A0
(en)
|
1999-08-24 |
2002-09-12 |
Medarex Inc |
Human ctla-4 antibodies and compositions containing the same
|
|
ES2246314T3
(es)
|
2000-01-20 |
2006-02-16 |
Universitat Zurich Institut Fur Medizinische Virologie |
Administracion intratumoral de moleculas desnudas de acido nucleico que codifican il-12.
|
|
US7183395B2
(en)
|
2000-01-28 |
2007-02-27 |
The Scripps Research Institute |
Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
|
|
US7468275B2
(en)
|
2000-01-28 |
2008-12-23 |
The Scripps Research Institute |
Synthetic internal ribosome entry sites and methods of identifying same
|
|
ES2164011B1
(es)
|
2000-02-25 |
2003-05-16 |
Inst Cientifico Tecnol Navarra |
Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos.
|
|
AU3958101A
(en)
|
2000-03-15 |
2001-09-24 |
Univ Pohang |
Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant
|
|
KR20020010206A
(ko)
|
2000-07-27 |
2002-02-04 |
이시우 |
인터루킨 12와 보조활성인자 ｂ7.1 유전자를 함유하는ｄｎａ 벡터 및 이벡터가 도입된 항암 세포백신
|
|
ATE490267T1
(de)
|
2001-06-05 |
2010-12-15 |
Curevac Gmbh |
Stabilisierte mrna mit erhöhtem g/c-gehalt, kodierend für ein virales antigen
|
|
AU2002354799A1
(en)
|
2001-07-03 |
2003-01-21 |
University Of Utah Research Foundation |
Soluble steroidal peptides for nucleic acid delivery
|
|
EP2390331B1
(en)
|
2001-09-28 |
2018-04-25 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
US7384739B2
(en)
|
2001-11-14 |
2008-06-10 |
Toyo Boseki Kabushiki Kaisha |
Compositions for enhancing DNA synthesis, DNA polymerase-related factors and utilization thereof
|
|
CA2409775C
(en)
|
2001-12-03 |
2010-07-13 |
F. Hoffmann-La Roche Ag |
Reversibly modified thermostable enzymes for dna synthesis and amplification in vitro
|
|
US20040005600A1
(en)
|
2002-04-01 |
2004-01-08 |
Evelina Angov |
Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
|
|
US7595303B1
(en)
|
2002-09-05 |
2009-09-29 |
University Of South Florida |
Genetic adjuvants for immunotherapy
|
|
DE10248141B4
(de)
|
2002-10-11 |
2007-04-19 |
Universitätsklinikum Hamburg-Eppendorf |
Nukleinsäuren und deren Verwendung für die Gentherapie
|
|
DE10260805A1
(de)
|
2002-12-23 |
2004-07-22 |
Geneart Gmbh |
Verfahren und Vorrichtung zum Optimieren einer Nucleotidsequenz zur Expression eines Proteins
|
|
AU2004247071B2
(en)
|
2003-05-30 |
2010-03-11 |
University Of South Florida |
Method for the treatment of malignancies
|
|
US7683036B2
(en)
|
2003-07-31 |
2010-03-23 |
Regulus Therapeutics Inc. |
Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
|
|
GB0329146D0
(en)
|
2003-12-16 |
2004-01-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
EP1640018A1
(en)
|
2004-09-24 |
2006-03-29 |
Universität Zürich |
Combinational therapy for treating cancer
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
US7550264B2
(en)
|
2005-06-10 |
2009-06-23 |
Datascope Investment Corporation |
Methods and kits for sense RNA synthesis
|
|
KR20080025181A
(ko)
|
2005-06-30 |
2008-03-19 |
아케믹스 코포레이션 |
완전 2'-변형된 핵산 전사체를 생성하기 위한 물질 및 방법
|
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
EP3611266B1
(en)
|
2005-08-23 |
2022-11-09 |
The Trustees of the University of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
EP2479254A1
(en)
|
2005-08-24 |
2012-07-25 |
The Scripps Research Institute |
Translation enhancer-element dependent vector systems
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
BRPI0620648B1
(pt)
|
2005-12-30 |
2022-12-20 |
Merck Patent Gesellschaft Mit Beschrãnkter Haftung |
Variante de il-12 p40, proteínas il-12, il-23 e de fusão, composição farmacêutica e uso da mesma
|
|
EP2487258B1
(en)
|
2006-01-05 |
2014-10-01 |
The Ohio State University Research Foundation |
MicroRNA-based methods for the diagnosis of colon, pancreas and stomach cancer
|
|
JP5490413B2
(ja)
|
2006-01-05 |
2014-05-14 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロｒｎａ発現異常
|
|
WO2007084364A2
(en)
|
2006-01-13 |
2007-07-26 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services, National Institutes Of Health |
Improved il-12 for expression in mammalian cells
|
|
KR101241477B1
(ko)
|
2006-01-27 |
2013-03-08 |
엘지이노텍 주식회사 |
질화물 반도체 발광소자 및 그 제조 방법
|
|
ES2448491T3
(es)
|
2006-03-02 |
2014-03-14 |
The Ohio State University Research Foundation |
Perfil de expresión de microARN asociado con cáncer de páncreas
|
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
|
CA2647282A1
(en)
|
2006-04-05 |
2007-10-11 |
Pfizer Products Inc. |
Ctla4 antibody combination therapy
|
|
US20080046192A1
(en)
|
2006-08-16 |
2008-02-21 |
Richard Lathrop |
Polypepetide-encoding nucleotide sequences with refined translational kinetics and methods of making same
|
|
WO2008036765A2
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Micrornas differentially expressed in pancreatic diseases and uses thereof
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
EP2087135B8
(en)
|
2006-11-01 |
2013-07-24 |
The Ohio State University Research Foundation |
Microrna expression signature for predicting survival and metastases in hepatocellular carcinoma
|
|
WO2008073915A2
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Micrornas differentially expressed in leukemia and uses thereof
|
|
WO2008078180A2
(en)
|
2006-12-22 |
2008-07-03 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
|
EP2150618B1
(en)
|
2007-05-04 |
2017-10-11 |
University Health Network |
Il-12 immunotherapy for cancer
|
|
US8415096B2
(en)
|
2007-05-23 |
2013-04-09 |
University Of South Florida |
Micro-RNAs modulating immunity and inflammation
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
HRP20131167T1
(hr)
|
2007-06-18 |
2014-01-03 |
Merck Sharp & Dohme B.V. |
Antitijela za humani receptor programirane smrti pd-1
|
|
US20090028857A1
(en)
|
2007-07-23 |
2009-01-29 |
Cell Genesys, Inc. |
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
|
|
TWI359030B
(en)
|
2007-08-24 |
2012-03-01 |
Univ Nat Taiwan |
Treatment of cellular proliferative disorders
|
|
US8476419B2
(en)
|
2007-09-14 |
2013-07-02 |
Vrije Universiteit Brussel |
Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
|
|
WO2009039198A2
(en)
|
2007-09-17 |
2009-03-26 |
The Trustees Of The University Of Pennsylvania |
Generation of hyperstable mrnas
|
|
JP5624471B2
(ja)
*
|
2007-09-24 |
2014-11-12 |
バーイラン ユニバーシティー |
磁性金属酸化物で被覆されたポリマー性ナノ粒子及びその使用
|
|
DK2205618T3
(en)
|
2007-09-26 |
2017-02-20 |
Intrexon Corp |
SYNTHETIC 5 'NON-TRANSLATED REGIONS, EXPRESSION VECTORS AND PROCEDURES FOR INCREASING TRANSGENIC EXPRESSION
|
|
JP2011505143A
(ja)
|
2007-11-30 |
2011-02-24 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
マイクロｒｎａ発現プロファイリング及び肺癌における末梢血ターゲティング
|
|
WO2009075886A1
(en)
|
2007-12-11 |
2009-06-18 |
The Scripps Research Institute |
Compositions and methods related to mrna translational enhancer elements
|
|
EP2072618A1
(en)
|
2007-12-14 |
2009-06-24 |
Johannes Gutenberg-Universität Mainz |
Use of RNA for reprogramming somatic cells
|
|
WO2009086558A1
(en)
*
|
2008-01-02 |
2009-07-09 |
Tekmira Pharmaceuticals Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
US20090263803A1
(en)
|
2008-02-08 |
2009-10-22 |
Sylvie Beaudenon |
Mirnas differentially expressed in lymph nodes from cancer patients
|
|
AU2009219193A1
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
MicroRNA signatures associated with human chronic lymphocytic leukemia (CCL) and uses thereof
|
|
AU2009238175C1
(en)
*
|
2008-04-15 |
2023-11-30 |
Arbutus Biopharma Corporation |
Novel lipid formulations for nucleic acid delivery
|
|
EP2112235A1
(en)
|
2008-04-24 |
2009-10-28 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Compositions and methods for microRNA expression profiling of nasopharyngeal carcinoma
|
|
US8715964B2
(en)
|
2008-05-11 |
2014-05-06 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Expression of IL-12 family heterodimers
|
|
US8401798B2
(en)
|
2008-06-06 |
2013-03-19 |
Dna Twopointo, Inc. |
Systems and methods for constructing frequency lookup tables for expression systems
|
|
US8126653B2
(en)
|
2008-07-31 |
2012-02-28 |
Dna Twopointo, Inc. |
Synthetic nucleic acids for expression of encoded proteins
|
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
|
US7561973B1
(en)
|
2008-07-31 |
2009-07-14 |
Dna Twopointo, Inc. |
Methods for determining properties that affect an expression property value of polynucleotides in an expression system
|
|
WO2009149539A1
(en)
|
2008-06-10 |
2009-12-17 |
Université de Montréal |
Enhancing antigen-specific cd8+ t cell response using irf-7 mrna
|
|
WO2010018563A2
(en)
|
2008-08-12 |
2010-02-18 |
Rosetta Genomics Ltd. |
Compositions and methods for the prognosis of lymphoma
|
|
CN102203132A
(zh)
|
2008-08-25 |
2011-09-28 |
安普利穆尼股份有限公司 |
Pd-1拮抗剂的组合物和使用方法
|
|
WO2010055487A2
(en)
|
2008-11-13 |
2010-05-20 |
Koninklijke Philips Electronics N.V. |
Compositions and methods for micro-rna expession profiling of colorectal cancer
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
EP2358902A1
(en)
|
2008-12-10 |
2011-08-24 |
Universität Regensburg |
Compositions and methods for micro-rna expression profiling of cancer stem cells
|
|
AU2010241864B2
(en)
|
2009-04-30 |
2014-02-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
US20120264626A1
(en)
|
2009-05-08 |
2012-10-18 |
The Ohio State University Research Foundation |
MicroRNA Expression Profiling and Targeting in Chronic Obstructive Pulmonary Disease (COPD) Lung Tissue and Methods of Use Thereof
|
|
MX342785B
(es)
|
2009-06-10 |
2016-10-12 |
Alnylam Pharmaceuticals Inc |
Formulacion mejorada de lipido.
|
|
BR112012002291A2
(pt)
|
2009-07-31 |
2016-11-29 |
Ethris Gmbh |
"polirribonucleotídeo com uma sequência que codifica uma proteína ou fragmento de proteína, implante, e, processo para a seleção de sequências de nucleotídeos"
|
|
EP2281579A1
(en)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Vaccine composition comprising 5'-Cap modified RNA
|
|
US20110082055A1
(en)
|
2009-09-18 |
2011-04-07 |
Codexis, Inc. |
Reduced codon mutagenesis
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
HUE042177T2
(hu)
|
2009-12-01 |
2019-06-28 |
Translate Bio Inc |
Szteroidszármazék mRNS szállítására humán genetikai betegségekben
|
|
WO2011076143A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expression profiling of lung cancer
|
|
WO2011076142A1
(en)
|
2009-12-24 |
2011-06-30 |
Fudan University |
Compositions and methods for microrna expession profiling in plasma of colorectal cancer
|
|
EP2341145A1
(en)
|
2009-12-30 |
2011-07-06 |
febit holding GmbH |
miRNA fingerprint in the diagnosis of diseases
|
|
WO2011094683A2
(en)
|
2010-01-29 |
2011-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Method of identifying myelodysplastic syndromes
|
|
EP2354246A1
(en)
|
2010-02-05 |
2011-08-10 |
febit holding GmbH |
miRNA in the diagnosis of ovarian cancer
|
|
US20130059015A1
(en)
|
2010-03-11 |
2013-03-07 |
H. Lee Moffitt Cancer Center & Research Institute |
Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
|
|
WO2011157294A1
(en)
|
2010-06-16 |
2011-12-22 |
Universita' Degli Studi Di Padova |
Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
|
|
US20130230884A1
(en)
|
2010-07-16 |
2013-09-05 |
John Chaput |
Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
|
|
EP2619307A1
(en)
|
2010-09-21 |
2013-07-31 |
RiboxX GmbH |
Method for synthesizing rna using dna template
|
|
WO2012072096A1
(en)
|
2010-12-03 |
2012-06-07 |
Biontech Ag |
Method for cellular rna expression
|
|
KR20120066952A
(ko)
|
2010-12-15 |
2012-06-25 |
주식회사 롤팩 |
7층 구조의 공압출 항균 진공포장 필름 및 그 제조방법
|
|
AU2011358150B2
(en)
|
2010-12-16 |
2016-11-03 |
Sprna Gmbh |
Pharmaceutical composition consisting of RNA having alkali metal as counter ion and formulated with dications
|
|
WO2012116714A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in elderly patients
|
|
CA2828940C
(en)
|
2011-03-10 |
2024-04-16 |
Provectus Pharmaceuticals, Inc. |
Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
WO2012151212A1
(en)
|
2011-05-01 |
2012-11-08 |
University Of Rochester |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof
|
|
WO2012150807A2
(ko)
|
2011-05-02 |
2012-11-08 |
엘지전자 주식회사 |
무선 접속 시스템에서 데이터 송수신 방법 및 이를 위한 기지국
|
|
WO2012153187A2
(en)
|
2011-05-06 |
2012-11-15 |
Xentech |
Markers for cancer prognosis and therapy and methods of use
|
|
PL3586861T3
(pl)
|
2011-06-08 |
2022-05-23 |
Translate Bio, Inc. |
Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
|
|
JP5965481B2
(ja)
|
2011-07-15 |
2016-08-03 |
レオ ファーマ アクティーゼルスカブ |
皮膚ｔ細胞リンパ腫（ｃｔｃｌ）の診断用マイクロｒｎａプロファイリング
|
|
EP2751292A4
(en)
|
2011-09-01 |
2015-05-20 |
Allegro Diagnostics Corp |
METHOD AND COMPOSITIONS FOR DETECTING CANCER BASED ON MIRNA EXPRESSION PROFILES
|
|
EP2755986A4
(en)
|
2011-09-12 |
2015-05-20 |
Moderna Therapeutics Inc |
MANIPULATED NUCLEIC ACIDS AND METHOD OF APPLICATION THEREFOR
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
CA3101783C
(en)
*
|
2011-10-11 |
2023-01-31 |
Universitat Zurich Prorektorat Mnw |
Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
|
|
WO2013066678A1
(en)
|
2011-10-26 |
2013-05-10 |
Georgetown University |
Microrna expression profiling of thyroid cancer
|
|
HRP20201595T1
(hr)
|
2011-11-28 |
2020-12-11 |
Merck Patent Gmbh |
Anti-pd-l1 protutijela i njihova uporaba
|
|
KR102277469B1
(ko)
|
2011-12-12 |
2021-07-15 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법
|
|
EP2623121A1
(en)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
CN113967253A
(zh)
|
2012-05-15 |
2022-01-25 |
百时美施贵宝公司 |
通过破坏pd-1/pd-l1信号传输的免疫治疗
|
|
EP2672197A1
(de)
|
2012-06-06 |
2013-12-11 |
Hörmann Energietechnik GmbH & Co. KG |
Montageanordnung zur dachseitigen Montage von Flächenkörpern an einem Bauwerk
|
|
US10245229B2
(en)
|
2012-06-08 |
2019-04-02 |
Translate Bio, Inc. |
Pulmonary delivery of mRNA to non-lung target cells
|
|
EP3536787A1
(en)
|
2012-06-08 |
2019-09-11 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
|
US20140020675A1
(en)
|
2012-07-18 |
2014-01-23 |
Chandrashekhar Sonwane |
Solar receiver
|
|
US9512456B2
(en)
|
2012-08-14 |
2016-12-06 |
Modernatx, Inc. |
Enzymes and polymerases for the synthesis of RNA
|
|
CN102876684B
(zh)
*
|
2012-09-17 |
2014-10-08 |
青岛康立泰药业有限公司 |
人白细胞介素-12的编码基因、真核宿主细胞和表达方法
|
|
WO2014093924A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
WO2014071963A1
(en)
|
2012-11-09 |
2014-05-15 |
Biontech Ag |
Method for cellular rna expression
|
|
WO2014081507A1
(en)
*
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
EP4331620A3
(en)
*
|
2012-12-07 |
2024-12-04 |
Translate Bio, Inc. |
Lipidic nanoparticles for mrna delivery
|
|
US20140200261A1
(en)
|
2013-01-17 |
2014-07-17 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
RU2718988C2
(ru)
|
2013-02-22 |
2020-04-15 |
Куревак Аг |
Комбинация противораковой рнк-вакцины и ингибитора пути pd-1 и ее применение
|
|
EP3608308B1
(en)
|
2013-03-08 |
2021-07-21 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US20160022840A1
(en)
|
2013-03-09 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Heterologous untranslated regions for mrna
|
|
KR20210122917A
(ko)
|
2013-03-14 |
2021-10-12 |
샤이어 휴먼 지네틱 테라피즈 인크. |
Cftr mrna 조성물 및 관련 방법 및 사용
|
|
CN105051213A
(zh)
|
2013-03-14 |
2015-11-11 |
夏尔人类遗传性治疗公司 |
信使rna加帽效率的定量评估
|
|
US20160184458A1
(en)
|
2013-03-14 |
2016-06-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
SG11201507474QA
(en)
|
2013-03-14 |
2015-10-29 |
Shire Human Genetic Therapies |
RIBONUCLEIC ACIDs WITH 4'-THIO-MODIFIED NUCLEOTIDES AND RELATED METHODS
|
|
DK2971098T3
(en)
|
2013-03-14 |
2019-02-18 |
Translate Bio Inc |
QUANTITATIVE ASSESSMENT FOR CAPE EFFECTIVENESS OF MESSENGER RNA
|
|
DK2970456T3
(da)
|
2013-03-14 |
2021-07-05 |
Translate Bio Inc |
Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer
|
|
PL3467108T3
(pl)
|
2013-03-14 |
2024-09-30 |
Translate Bio, Inc. |
Sposoby oczyszczania informacyjnego rna
|
|
US10130649B2
(en)
|
2013-03-15 |
2018-11-20 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
SG11201510747RA
(en)
|
2013-08-21 |
2016-03-30 |
Curevac Ag |
Method for increasing expression of rna-encoded proteins
|
|
EA034666B1
(ru)
|
2013-09-13 |
2020-03-04 |
Бейджин Свитзерланд Гмбх |
Антитело против pd-1 и его применение для лечения рака или вирусной инфекции и фрагмент антитела
|
|
JP6558699B2
(ja)
|
2013-10-01 |
2019-08-14 |
国立大学法人三重大学 |
抗原提示を促進するエピトープ間配列を含むｔ細胞誘導ワクチン
|
|
AU2014337156A1
(en)
|
2013-10-18 |
2016-05-12 |
Modernatx, Inc. |
Compositions and methods for tolerizing cellular systems
|
|
EA034103B1
(ru)
|
2013-10-22 |
2019-12-27 |
Транслейт Био, Инк. |
СПОСОБ ЛЕЧЕНИЯ ФЕНИЛКЕТОНУРИИ С ПРИМЕНЕНИЕМ мРНК
|
|
MX2016005238A
(es)
|
2013-10-22 |
2016-08-12 |
Shire Human Genetic Therapies |
Formulaciones de lipidos para la administracion de acido ribonucleico mensajero.
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
AU2014364606A1
(en)
*
|
2013-12-17 |
2016-07-07 |
Genentech, Inc. |
Combination therapy comprising OX40 binding agonists and PD-1 axis binding antagonists
|
|
JP2017501712A
(ja)
*
|
2013-12-18 |
2017-01-19 |
イントレキソン コーポレーション |
単鎖ｉｌ−１２核酸、ポリペプチド、およびそれらの使用
|
|
KR102399799B1
(ko)
|
2013-12-30 |
2022-05-18 |
큐어백 아게 |
인공 핵산 분자
|
|
CA2927254C
(en)
|
2013-12-30 |
2023-10-24 |
Curevac Ag |
Artificial nucleic acid molecules
|
|
SG10201912038TA
(en)
*
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
SMT202200502T1
(it)
*
|
2014-06-25 |
2023-01-13 |
Acuitas Therapeutics Inc |
Nuovi lipidi e formulazioni di nanoparticelle lipidiche per l'erogazione di acidi nucleici
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
RU2749113C2
(ru)
|
2015-04-22 |
2021-06-04 |
Куревак Аг |
Содержащая рнк композиция для лечения опухолевых заболеваний
|
|
US10682401B2
(en)
|
2015-05-19 |
2020-06-16 |
Morphogenesis, Inc. |
Multi-indication mRNA cancer immunotherapy
|
|
CA2985087C
(en)
|
2015-05-19 |
2021-02-16 |
Morphogenesis, Inc. |
Cancer vaccine comprising mrna encoding a m-like-protein
|
|
EP4286012A3
(en)
*
|
2015-09-17 |
2024-05-29 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
EP3205356A1
(en)
|
2016-02-10 |
2017-08-16 |
Onkoloski Institut Ljubljana |
Plasmid expression vector encoding human interleukin 12 under transcriptional control of p21 promoter and without antibiotic resistance for cancer gene therapy and other uses thereof
|
|
EP3211000B1
(en)
|
2016-02-25 |
2019-01-30 |
Provecs Medical GmbH |
Novel immunostimulating vector system
|
|
KR102469450B1
(ko)
|
2016-05-18 |
2022-11-22 |
모더나티엑스, 인크. |
인터류킨-12 (il12)를 코딩하는 폴리뉴클레오티드 및 그의 용도
|
|
MX2019001920A
(es)
|
2016-08-19 |
2019-07-01 |
Curevac Ag |
Arn la terapia contra el cancer.
|
|
JP2019532648A
(ja)
|
2016-10-07 |
2019-11-14 |
ボード オブ リージェンツ ザ ユニヴァーシティ オブ テキサス システム |
がんの治療のための膜係留ｉｌ−１２を発現しているｔ細胞
|